Jennifer Fogarty, Ph.D. is the Chief Scientific Officer for the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine and the Director of Applied Health and Performance at Sophic Synergistics LLC. With more than twenty years of experience in medical physiology and human health and performance in extreme environments, her mission is to increase access to high-quality healthcare in space and on Earth, by empowering astronauts, patients, and medical providers with evidenced-based precision medicine and technologies. As Chief Scientist of TRISH, Dr. Fogarty leads an innovative, high-risk research and development portfolio to address space exploration’s most challenging human health and performance risks. In her role at Sophic Synergistics, a women-owned and led human-centered design firm, Dr. Fogarty guides a division focused on developing and expanding medical technologies for use in remote medicine, telemedicine, and home healthcare. As a former NASA Human Research Program Chief Scientist, Jennifer prioritized communication and collaboration between industry, academia, government, commercial spaceflight programs, and international partners. She continues to value and seek partnerships to discover and assess fundamental and mechanistic discoveries that lead to innovative prevention and treatments to sustain health and performance. Dr. Fogarty received her Ph.D. in Medical Sciences from Texas A&M University College of Medicine. Other appointments include Assistant Professor in both Baylor College of Medicine’s Center for Space Medicine and Department of Medicine; Editor of the Fundamentals of Aerospace Medicine, 4th and 5th editions; and Associate Editor for the journal npj Microgravity.
The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine.
